Important: Therapy notes
MHRA alert: Carbimazole: risk of acute pancreatitis (February 2019) (www.gov.uk).
MHRA alert: Carbimazole: increased risk of congenital malformations; strengthened advice on contraception (February 2019 (www.gov.uk).
Risk minimisation materials
Important: Formulation and dosage details
Tablets 5mg, 20mg (specialist use only)
Initially 20 to 40mg once daily. Repeat TFTs after 4 to 6 weeks and adjust the dose following specialist advice.